ストックスクリーナーアプリを入手
2.36
5.98%
-0.15
アフターアワーズ：
2.36
前日終値:
$2.51
開ける：
$2.55
24時間の取引高:
185.78K
Relative Volume:
0.93
時価総額：
$21.19M
収益：
$93.76M
当期純損益:
$-13.68M
株価収益率:
-0.8973
EPS:
-2.63
ネットキャッシュフロー:
$8.77M
1週間 パフォーマンス:
+24.21%
1か月 パフォーマンス:
+3.51%
6か月 パフォーマンス:
+131.37%
1年 パフォーマンス:
+5.36%
1日の値動き範囲:
$2.35
$2.59
1週間の範囲:
$1.96
$2.59
52週間の値動き範囲:
$0.95
$2.82
Aytu Biopharma Inc Stock (AYTU) Company Profile
AYTU を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AYTU
Aytu Biopharma Inc
|
2.36 | 24.88M | 93.76M | -13.68M | 8.77M | -2.63 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-01 | 開始されました | Lake Street | Buy |
| 2025-06-30 | 開始されました | Ascendiant Capital Markets | Buy |
| 2021-03-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-05-29 | 開始されました | H.C. Wainwright | Buy |
Aytu Biopharma Inc (AYTU) 最新ニュース
What earnings revisions data tells us about Aytu BioPharma Inc.2025 Key Highlights & Precise Buy Zone Tips - newser.com
Using data models to predict Aytu BioPharma Inc. stock movementMarket Weekly Review & Low Volatility Stock Suggestions - newser.com
Aytu BioPharma to Present at Upcoming October 2025 Conferences - ACCESS Newswire
How to use Fibonacci retracement on Aytu BioPharma Inc.Analyst Upgrade & Community Supported Trade Ideas - newser.com
Why institutional investors increase stakes in Aytu BioPharma Inc. (AY20) stockAnalyst Upgrade & Verified Swing Trading Watchlists - newser.com
How institutional ownership impacts Aytu BioPharma Inc. stockWeekly Trade Analysis & Reliable Volume Spike Trade Alerts - newser.com
Aytu BioPharma Inc AY20 Stock Analysis and ForecastMomentum Trading Signals & Free Double Digit Growth Tips - earlytimes.in
What analysts say about Aytu BioPharma Inc stockTake Profit Strategies & Fast Profit Trading Tips - earlytimes.in
Is Aytu BioPharma Inc. (AY20) stock attractive for growth fundsJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Can Aytu BioPharma Inc. (AY20) stock withstand sector downturnsEarnings Growth Report & Entry Point Strategy Guides - newser.com
Aytu BioPharma Reports Fiscal 2025 Earnings and EXXUA Launch Plans - MSN
Will Rising Interest Rates Hurt Lupin Limited’s Profit MarginsMarket Correction Analysis & Set Up Real-Time Alerts – It’s Free - earlytimes.in
Aytu BioPharma Inc. stock momentum explainedJuly 2025 Snapshot & High Accuracy Trade Alerts - newser.com
Applying sector rotation models to Aytu BioPharma Inc.Market Performance Report & Technical Pattern Recognition Alerts - newser.com
Aytu outlines EXXUA launch targeting $22B MDD market while streamlining ADHD portfolio - MSN
Is It Time to Lock in Profits on Mefcom Capital Markets Limited StockValue Stock Picks & Minimal Investment Capital Gains - earlytimes.in
What drives Aytu BioPharma Inc AY20 stock priceInterest Rate Changes & Minimal Risk High Reward - earlytimes.in
Aytu BioPharma at Lytham Partners: Strategic Realignment and Growth By Investing.com - Investing.com Canada
Aytu BioPharma (NASDAQ:AYTU) Downgraded by Wall Street Zen to “Hold” - Defense World
Aytu BioPharma (NASDAQ:AYTU) Given New $12.50 Price Target at Ascendiant Capital Markets - Defense World
Ascendiant Capital Maintains Aytu BioPharma (AYTU) Buy Recommendation - Nasdaq
Maxim Group Maintains Aytu BioPharma (AYTU) Buy Recommendation - Nasdaq
Aytu Biopharma Inc (AYTU) 財務データ
収益
当期純利益
現金流量
EPS
Aytu Biopharma Inc (AYTU) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Disbrow Joshua R. | Chief Executive Officer |
Jun 09 '25 |
Buy |
1.50 |
66,666 |
99,999 |
153,257 |
| Disbrow Joshua R. | Chief Executive Officer |
Feb 28 '25 |
Buy |
1.30 |
15,000 |
19,500 |
86,591 |
1.54%
1.20%
大文字化:
|
ボリューム (24 時間):